Foreign Travel Advice - UK

Tarlatamab approved to treat adult patients with small cell lung cancer 

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 31 December 2024, approved the medicine tarlatamab (Imdyllytra) to treat adult patients with small cell lung cancer (SCLC) that has spread throughout …

Read the original advice at Foreign Travel Advice (UK)

Related Articles

Back to top button